Company
Advemto
Mapping complex cell function to genetic sequence at massive scale.
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Customers
- next-generation therapeutics and TechBio
Claim, correct or request removal
Record updated 20 September 2026
About
Eliminating the preclinical validation bottleneck for next-generation therapeutics and TechBio.
Loading relationship preview